Cite Filings / ALDX / 0001193125-21-008136

Feed Companies Filings Check

Sign in

424B5

Prospectus

Aldeyra Therapeutics, Inc. Filed 2021-01-13 Acc 0001193125-21-008136

Documents 1

424B5 Prospectus , d11417d424b5.htm

Around this filing

2021-01-14 424B5 Prospectus
2021-01-14 8-K Material agreement · Other events
2021-01-13 424B5 Prospectus
2021-01-11 4 10% owner bought 1,050,000 shares at an average $8.76 ($9,202,668)
2021-01-07 8-K Regulation FD disclosure · Other events
2018-12-28 424B5 Prospectus

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading d11417d424b5.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…